Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Boyiadzis

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Aging|October 1, 2015
AML treatment in older adultsAlison Sehgal, Michael Boyiadzis
Expert Opinion on Pharmacotherapy|December 19, 2003
Haematopoietic stem cell transplantation: indications, clinical developments and future directionsMichael Boyiadzis, Steven Pavletic
Current Opinion in Hematology|May 31, 2018
Exosomes in acute myeloid leukemia inhibit hematopoiesisMichael Boyiadzis, Theresa L Whiteside
Expert Opinion on Biological Therapy|July 11, 2008
Approved monoclonal antibodies for cancer therapyMichael Boyiadzis, Kenneth A Foon
Expert Opinion on Biological Therapy|September 23, 2006
Natural killer cells: from bench to cancer therapyMichael Boyiadzis, Kenneth A Foon
Expert Review of Molecular Diagnostics|April 5, 2016
Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?Michael Boyiadzis, Theresa L Whiteside
Blood Reviews|February 18, 2015
Information transfer by exosomes: A new frontier in hematologic malignanciesMichael Boyiadzis, Theresa L Whiteside
Urologia Internationalis|March 10, 2005
Fulminant hepatic failure secondary to metastatic prostate cancerMichael Boyiadzis, Myung Nam, William Dahut
Expert Opinion on Biological Therapy|June 4, 2015
Programmed death-1 checkpoint blockade in acute myeloid leukemiaAlison Sehgal, Theresa L Whiteside, Michael Boyiadzis
Expert Opinion on Biological Therapy|November 24, 2007
Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable diseaseMichael Boyiadzis, Kenneth A Foon, Steven Pavletic
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Aging|October 1, 2015
AML treatment in older adultsAlison Sehgal, Michael Boyiadzis
Expert Opinion on Pharmacotherapy|December 19, 2003
Haematopoietic stem cell transplantation: indications, clinical developments and future directionsMichael Boyiadzis, Steven Pavletic
Current Opinion in Hematology|May 31, 2018
Exosomes in acute myeloid leukemia inhibit hematopoiesisMichael Boyiadzis, Theresa L Whiteside
Expert Opinion on Biological Therapy|July 11, 2008
Approved monoclonal antibodies for cancer therapyMichael Boyiadzis, Kenneth A Foon
Expert Opinion on Biological Therapy|September 23, 2006
Natural killer cells: from bench to cancer therapyMichael Boyiadzis, Kenneth A Foon
Expert Review of Molecular Diagnostics|April 5, 2016
Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?Michael Boyiadzis, Theresa L Whiteside
Blood Reviews|February 18, 2015
Information transfer by exosomes: A new frontier in hematologic malignanciesMichael Boyiadzis, Theresa L Whiteside
Urologia Internationalis|March 10, 2005
Fulminant hepatic failure secondary to metastatic prostate cancerMichael Boyiadzis, Myung Nam, William Dahut
Expert Opinion on Biological Therapy|June 4, 2015
Programmed death-1 checkpoint blockade in acute myeloid leukemiaAlison Sehgal, Theresa L Whiteside, Michael Boyiadzis
Expert Opinion on Biological Therapy|November 24, 2007
Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable diseaseMichael Boyiadzis, Kenneth A Foon, Steven Pavletic
Pageof 9